Peter Calverley

Peter is a seasoned business executive whose experience has primarily been with Silicon Valley technology companies. Since the late ‘90’s he has been either CFO or COO with a number of venture/corporate backed companies. Most recently he has served as the CFO for California-based Tela Innovations, Inc. Tela, a leader in intellectual property for next-generation semiconductor design and manufacturing, successfully licensed its patented technology to such companies as Qualcomm, TSMC and Samsung. Prior to his work with earlier stage technology companies Peter held executive positions with such notable Silicon Valley firms as Cadence Design Systems, UB Networks, ROLM and Atari.

Peter is currently the Executive Chairman of Syantra, Inc. in Calgary which is an emerging life sciences company focused on patented testing for the early detection of cancer with the initial test focusing on breast cancer. He is also a board member and actively involved with the Calgary Biohubx project. Biohubx has partnered with Dynalife Medical Labs and the federal government to foster growth companies in the life sciences in Calgary.

Peter is an active member in both the A100 and C100 organizations that are focused on having experienced technology executives help with mentoring Canadian technology entrepreneurs. He recently completed his ICD.D designation through the Institute of Corporate Directors in conjunction with the Rotman School of Business at the University of Toronto. He also holds CPA, CMA and MBA, Finance distinctions.

Peter joined the Orpyx® Medical Technologies Inc. Board of Directors as Executive Chairperson in 2021.